Comparison of the specificity of homo- and heterodimeric linked HIV-1 and HIV-2 proteinase dimers

被引:11
作者
Bagossi, P
Cheng, YSE
Oroszlan, S
Tözsér, J
机构
[1] Debrecen Univ Med, Sch Med, Dept Biochem & Mol Biol, H-4012 Debrecen, Hungary
[2] Dupont Merck Pharmaceut Co, Expt Stn, Wilmington, DE 19803 USA
[3] NCI, Mol Virol & Carcinogenesis Lab, ABL Basic Res Program, Frederick Canc Res & Dev Ctr, Frederick, MD 21702 USA
来源
PROTEIN ENGINEERING | 1998年 / 11卷 / 06期
关键词
linked HIV proteinase dimers; heterodimers; oligo-peptide substrates; enzyme kinetics; substrate specificity;
D O I
10.1093/protein/11.6.439
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The specificity of linked homo- and heterodimeric HIV-1 and HIV-2 proteinases was characterized by using oligopeptide substrates, For two substrates the k(cat)/K-m values for the heterodimers were the mean values for those of the homodimers, suggesting that these substrates could productively bind into the heterodimers in both directions, However, for two other substrates the k(cat)/K-m values for the heterodimers were higher than those of the homodimers, suggesting that these substrates could productively bind into the enzymes in a preferable direction. However, the mode of binding does not seem to depend on the sequential position of the subunits, The studied linked homo- and heterodimers may represent intermediate stages in the evolution of bilobal aspartic proteinases. As divergence in sequence of the two halves of such a proteinase increases, the possibility of bidirectional binding is likely lost at the expense of the optimized side-chain subsite interactions. The differences in observed and calculated k(cat)/K-m values revealed dependence of the substrate specificity at one subsite of the enzyme from the next residue in sequence of substrate. These findings were also supported by molecular modeling studies.
引用
收藏
页码:439 / 445
页数:7
相关论文
共 44 条
[21]  
MULICHAK AM, 1993, J BIOL CHEM, V268, P13103
[22]   ANTIVIRAL ACTIVITY OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROTEASE INHIBITORS IN A SINGLE-CYCLE OF INFECTION - EVIDENCE FOR A ROLE OF PROTEASE IN THE EARLY PHASE [J].
NAGY, K ;
YOUNG, M ;
BABOONIAN, C ;
MERSON, J ;
WHITTLE, P ;
OROSZLAN, S .
JOURNAL OF VIROLOGY, 1994, 68 (02) :757-765
[23]  
OROSZLAN S, 1990, CURR TOP MICROBIOL, V157, P153
[24]   HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 AND TYPE-2 PROTEASE MONOMERS ARE FUNCTIONALLY INTERCHANGEABLE IN THE DIMERIC ENZYMES [J].
PATTERSON, CE ;
SEETHARAM, R ;
KETTNER, CA ;
CHENG, YSE .
JOURNAL OF VIROLOGY, 1992, 66 (02) :1228-1231
[25]   HYDROLYSIS OF SYNTHETIC CHROMOGENIC SUBSTRATES BY HIV-1 AND HIV-2 PROTEINASES [J].
PHYLIP, LH ;
RICHARDS, AD ;
KAY, J ;
KONVALINKA, J ;
STROP, P ;
BLAHA, I ;
VELEK, J ;
KOSTKA, V ;
RITCHIE, AJ ;
BROADHURST, AV ;
FARMERIE, WG ;
SCARBOROUGH, PE ;
DUNN, BM .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1990, 171 (01) :439-444
[26]   STRUCTURAL AND EVOLUTIONARY RELATIONSHIPS BETWEEN RETROVIRAL AND EUKARYOTIC ASPARTIC PROTEINASES [J].
RAO, JKM ;
ERICKSON, JW ;
WLODAWER, A .
BIOCHEMISTRY, 1991, 30 (19) :4663-4671
[27]   UFF, A FULL PERIODIC-TABLE FORCE-FIELD FOR MOLECULAR MECHANICS AND MOLECULAR-DYNAMICS SIMULATIONS [J].
RAPPE, AK ;
CASEWIT, CJ ;
COLWELL, KS ;
GODDARD, WA ;
SKIFF, WM .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1992, 114 (25) :10024-10035
[28]  
Ridky TW, 1996, J BIOL CHEM, V271, P4709, DOI 10.1074/jbc.271.9.4709
[29]   INSITU PROCESSING OF A RETROVIRAL NUCLEOCAPSID PROTEIN BY THE VIRAL PROTEINASE [J].
ROBERTS, MM ;
COPELAND, TD ;
OROSZLAN, S .
PROTEIN ENGINEERING, 1991, 4 (06) :695-700
[30]   THE PREPARATION AND BIOCHEMICAL-CHARACTERIZATION OF INTACT CAPSIDS OF EQUINE INFECTIOUS-ANEMIA VIRUS [J].
ROBERTS, MM ;
OROSZLAN, S .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1989, 160 (02) :486-494